Stock listing

Frankfurt:2TG STERIS plc (Ireland) Aktie

German listing (Frankfurt) of STERIS plc (Ireland) · home listing NYSE:STE

Follow STERIS plc (Ireland) into a list and get an email when it puts out news.

Share price · FWB:2TG

€233.40 EUR +2.80 (+1.2%)

Close on Nov 20, 2026

Past year +1.2% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€221.80 – €233.40 EURNov 20, 2026
Market cap
€22.76B EURAt the close on Nov 20, 2026 · price × 97.50M shares outstanding
52-week range
€163.81 – €233.40 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€2,005 EURMedian day 0 shares · 45 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
STERIS plc (Ireland) logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:STE · Home$255.76 USD-3.81 (-1.5%)823,416$257.05$259.35$254.99$259.57Close on Nov 20, 2026
Frankfurt:2TG€233.40 EUR+2.80 (+1.2%)—€221.80€233.40€221.80€230.60Close on Nov 20, 2026
B3:S1TE3452.14 BRL0.00 (0.0%)—52.1452.1452.1452.14Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:2TG · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€225.23+13.67+6.5%€218.08€225.80€217.935
€211.56+15.91+8.1%€211.56€211.56€211.5656
€195.64-2.964-1.5%€195.64€195.64€195.6456
€198.61-7.156-3.5%€198.61€198.61€198.610
€205.76+4.932+2.5%€196.14€205.85€194.950
€200.83+1.384+0.7%€200.71€200.93€200.35104
€199.45+0.967+0.5%€199.45€199.45€199.4534
€198.48-1.734-0.9%€198.48€198.48€198.480
€200.21+2.318+1.2%€200.21€200.21€200.210
€197.90-7.538-3.7%€197.90€197.90€197.900
€205.43+20.63+11.2%€199.56€205.50€199.5510
€184.81-7.96-4.1%€184.81€184.81€184.810
€192.77-6.344-3.2%€192.77€192.77€192.770
€199.11+3.19+1.6%€189.85€199.25€189.2210
€195.92+0.40+0.2%€191.96€198.97€189.440
€195.52+11.46+6.2%€191.70€196.10€191.060
€184.06-1.395-0.8%€184.06€184.06€184.060
€185.46-0.724-0.4%€185.46€185.46€185.460
€186.18-8.132-4.2%€186.18€186.18€186.180
€194.31+15.76+8.8%€183.63€194.53€181.210
€178.55+0.378+0.2%€178.55€178.55€178.550
€178.17-0.168-0.1%€178.17€178.17€178.172
€178.34+0.092+0.1%€178.34€178.34€178.340
€178.25-10.03-5.3%€178.25€178.25€178.250
€188.27+3.617+2.0%€181.64€188.95€181.03176
€184.66+6.479+3.6%€178.05€185.54€177.480
€178.18+2.33+1.3%€178.18€178.18€178.180
€175.85+0.202+0.1%€175.85€175.85€175.850
€175.65-9.094-4.9%€175.65€175.65€175.650
€184.74+3.789+2.1%€174.98€186.04€172.660
€180.95-3.53-1.9%€175.99€182.72€174.400
€184.48+2.03+1.1%€174.97€184.56€174.380
€182.45+1.733+1.0%€174.29€183.24€173.140
€180.72+3.166+1.8%€172.31€180.86€171.130
€177.55+0.199+0.1%€172.28€179.57€172.150
€177.35-2.936-1.6%€174.20€178.99€174.000
€180.29-0.040.0%€176.59€181.27€175.800
€180.33-3.635-2.0%€174.20€181.53€174.170
€183.96+2.115+1.2%€175.03€186.13€174.220
€181.85+0.103+0.1%€173.77€182.03€172.010
€181.75-0.479-0.3%€176.32€182.91€176.280
€182.22-2.58-1.4%€177.41€182.62€176.8520
€184.80-2.044-1.1%€182.36€185.13€181.520
€186.85-2.123-1.1%€184.22€187.63€182.860
€188.97-3.605-1.9%€186.09€189.90€185.320
€192.58+1.411+0.7%€187.33€193.34€187.210
€191.17-11.55-5.7%€191.17€191.17€191.170
€202.71+10.51+5.5%€190.77€202.96€190.6240
€192.21-5.526-2.8%€192.21€192.21€192.210
€197.73-1.812-0.9%€193.81€198.20€193.450
€199.54-1.234-0.6%€191.81€200.41€190.240
€200.78+7.905+4.1%€195.57€201.06€195.430
€192.87-2.137-1.1%€192.87€192.87€192.870
€195.01+1.121+0.6%€195.01€195.01€195.010
€193.89-8.956-4.4%€193.89€193.89€193.890
€202.84+8.279+4.3%€194.70€203.84€192.1666
€194.57+3.769+2.0%€194.57€194.57€194.570
Ticker
Frankfurt:2TG
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All STERIS plc (Ireland) news

STERIS plc (Ireland) on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
17 in the last 12 months · 27 in all · newest Nov 4, 2026 · oldest 2025
Calls
29 calls with a replay · 29 with a transcript · latest Aug 6, 2026
Decks
14 decks · latest August 2026

Where STERIS plc (Ireland) is listed

ListingExchangeCountryCurrency
NYSE:STE · Home listingNYSEUnited StatesUSD
LS Exchange:A2PGLVLS ExchangeGermanyEUR
gettex:2TGgettexGermanyEUR
BX Swiss:STEBX SwissSwitzerlandCHF
Lang & Schwarz:A2PGLVLang & SchwarzGermanyEUR
BMV:STENBMVMexicoMXN
Tradegate:2TGTradegateGermanyEUR
BOATS:STEBOATSUnited StatesUSD
Frankfurt:2TG · This pageFrankfurtGermanyEUR
LSE:0XI8LSEUnited KingdomEUR
B3:S1TE34B3BrazilBRL
Dusseldorf:2TGDusseldorfGermanyEUR
Munich:2TGMunichGermanyEUR
BIVA:STENBIVAMexicoMXN
Hamburg:2TGHamburgGermanyEUR
Hanover:2TGHanoverGermanyEUR
Stuttgart:2TGStuttgartGermanyEUR

Valuation

P/E 30.2× against a median of 29.3×: 7th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$26.30B USD
P/E
30.2×
EV/sales
4.3×
EV/EBITDA
15.8×
Price/book
3.4×
Gross margin
44.6%
Operating margin
19.0%
Net margin
13.4%
Debt to equity
0.3×
Beta vs S&P 500
0.40

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
STERIS plc (Ireland) · NYSE:STEUS$24.94BUS$26.30B30.2×4.3×15.8×3.4×13.4%0.3×0.40
GE HealthCare Technologies Inc. · NASDAQ:GEHCUS$36.46BUS$43.61B16.9×2.0×13.7×3.1×10.0%0.9×0.65
Alcon AG · SIX:ALCUS$35.86BUS$38.74B54.0×3.5×16.1×1.6×6.1%0.2×n/a
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A · SZSE:300760US$33.36BUS$30.38B28.7×5.9×n/a5.4×22.4%0.0×n/a
ResMed Inc. · NYSE:RMDUS$33.14BUS$32.54B20.8×5.7×15.6×5.6×27.8%0.1×0.48
DexCom, Inc. · NASDAQ:DXCMUS$29.58BUS$28.62B29.9×5.6×n/a11.7×19.4%0.0×0.71
Koninklijke Philips N.V. · EURONEXT:PHIAUS$28.31BUS$34.23B27.0×1.8×10.0×2.2×5.4%0.7×n/a
Sonova Holding AG · SIX:SOONUS$20.69BUS$21.87B40.4×5.1×19.6×6.7×11.9%0.7×n/a
Straumann Holding AG · SIX:STMNUS$20.27BUS$20.39B47.8×6.6×24.6×7.5×13.7%0.2×n/a
Zimmer Biomet Holdings, Inc. · NYSE:ZBHUS$19.13BUS$26.24B24.9×3.1×11.6×1.5×8.9%0.6×0.40
Coloplast A/S Class B · OMXCOP:COLO_BUS$15.08BUS$18.16B33.4×4.3×10.5×7.2×10.6%1.5×n/a
Median of the othersUS$28.95BUS$29.50B29.3×4.7×14.6×5.5×11.3%0.4×0.56

Forecasts

4 strong buy · 1 buy · 3 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
281.14 USD · Analysts' mean
EPS, year to Mar 2027
11.44 · 8 analysts
Revenue, year to Mar 2027
6.39B · 8 analysts

Team and board

Officers

OfficerRole
Julie WinterVice President, Investor Relations and Corporate Communications

Board

DirectorRole
Pierre BouludDirector

Events

Calls

CallWhenStatus
STERIS plc (Ireland) (NYSE:STE) Q1 2027 Earnings CallThu, Aug 06, 2026 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q4 2026 Earnings CallTue, May 12, 2026 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q3 2026 Earnings CallThu, Feb 05, 2026 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q2 2026 Earnings CallThu, Nov 06, 2025 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q1 2026 Earnings CallThu, Aug 07, 2025 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q4 2025 Earnings CallThu, May 15, 2025 · 12:00 PM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q3 2025 Earnings CallThu, Feb 06, 2025 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q2 2025 Earnings CallThu, Nov 07, 2024 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q1 2025 Earnings CallWed, Aug 07, 2024 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q4 2024 Earnings CallThu, May 09, 2024 · 9:00 AM ETReplay
All 29 calls
CallWhenStatus
STERIS plc (Ireland) (NYSE:STE) Q3 2024 Earnings CallThu, Feb 08, 2024 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q2 2024 Earnings CallWed, Nov 08, 2023 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q1 2024 Earnings CallWed, Aug 02, 2023 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q4 2023 Earnings CallThu, May 11, 2023 · 9:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q3 2023 Earnings CallThu, Feb 09, 2023 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q2 2023 Earnings CallThu, Nov 10, 2022 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q1 2023 Earnings CallWed, Aug 03, 2022 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q4 2022 Earnings CallThu, May 12, 2022 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q3 2022 Earnings CallWed, Feb 09, 2022 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q2 2022 Earnings CallWed, Nov 03, 2021 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q1 2022 Earnings CallTue, Aug 10, 2021 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q4 2021 Earnings CallWed, May 19, 2021 · 11:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q3 2021 Earnings CallWed, Feb 03, 2021 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q2 2021 Earnings CallTue, Nov 03, 2020 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q1 2021 Earnings CallMon, Aug 03, 2020 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q4 2020 Earnings CallThu, May 14, 2020 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q3 2020 Earnings CallTue, Feb 11, 2020 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q2 2020 Earnings CallTue, Nov 05, 2019 · 10:00 AM ETReplay
STERIS plc (Ireland) (NYSE:STE) Q1 2020 Earnings CallTue, Aug 06, 2019 · 10:00 AM ETReplay

Results days

QuarterResultsShare move
Q2 2027Nov 4, 2026 · After close+2.5%
Q1 2027Aug 5, 2026 · After close−0.4%
Q4 2026May 11, 2026 · After close+4.5%
Q3 2026Feb 4, 2026 · After close−7.7%
Q2 2026Nov 5, 2025 · After close+6.9%
Q1 2026Aug 6, 2025 · After close+6.8%
Q4 2025May 14, 2025 · After close+8.5%
Q3 2025Feb 5, 2025 · After close+2.1%
Q2 2025Nov 6, 2024 · After close−5.3%
Q1 2025Aug 6, 2024 · After close−2.4%
All 20 quarters
QuarterResultsShare move
Q4 2024May 8, 2024 · After close+7.6%
Q3 2024Feb 7, 2024 · After close−2.5%
Q2 2024Nov 7, 2023 · After close−5.5%
Q1 2024Aug 1, 2023 · After close+1.7%
Q4 2023May 10, 2023 · After close+9.8%
Q3 2023Feb 8, 2023 · After close−10.9%
Q2 2023Nov 9, 2022 · After close+5.2%
Q1 2023Aug 2, 2022 · After close−9.6%
Q4 2022May 11, 2022 · After close+2.7%
Q3 2022Feb 8, 2022 · After close+2.9%

Open Events

Decks

DeckKindSlidesDate
STERIS — Investor Presentation (August 2026)Investor deck21 slidesAugust 2026
STERIS — Merger or Acquisition (January 2021)Merger or acquisition16 slidesJan 12, 2021
Steris — Merger or Acquisition (October 2014)Merger or acquisition15 slidesOct 14, 2014
Steris — Investor Presentation (November 2009)Investor deck42 slidesNovember 2009
STERIS — Investor Day (November 2005)Investor day94 slidesNov 15, 2005
STERIS — SG Cowen Healthcare Conference 2005Conference15 slidesMar 16, 2005
STERIS — UBS Global Life Sciences Conference 2004Conference31 slidesSep 28, 2004
STERIS — Thomas Weisel Partners Healthcare Tailwinds 2004Conference7 slidesSep 8, 2004
STERIS — GARP Investors Conference 2004Conference27 slidesJun 16, 2004
STERIS — SG Cowen Health Care Conference 2004Conference28 slidesMar 10, 2004
All 14 decks
DeckKindSlidesDate
STERIS — US Bancorp Piper Jaffray Health Care Conference 2004Conference28 slidesJan 28, 2004
Steris — JPMorgan Healthcare Conference 2004Conference25 slidesJan 12, 2004
STERIS — UBS Global Life Sciences Conference 2003Conference35 slidesSep 24, 2003
STERIS — Investor Day (September 2003)Investor day112 slidesSep 4, 2003

Open Decks

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue5.94B5.46B5.14B4.54B4.22B3.11B3.03B2.78B2.62B2.61B
Cost of revenue3.31B3.06B2.92B2.56B2.34B1.76B1.71B1.61B1.53B1.59B
Gross profit2.63B2.40B2.22B1.98B1.88B1.34B1.32B1.17B1.09B1.03B
Research and development112.9M107.6M103.7M98.5M86.7M66.3M65.5M63.0M60.8M59.4M
Selling, general and administrative1.41B1.33B1.25B1.09B1.32B731.3M716.7M669.9M632.0M682.0M
Operating income1.10B866.6M836.1M791.1M477.8M548.4M537.0M411.0M399.9M226.2M
Depreciation and amortization486.5M476.2M565.2M552.9M553.1M219.2M197.2M225.9M178.3M188.1M
EBITDA1.59B1.34B1.40B1.34B1.03B767.6M734.3M636.9M578.2M414.3M
Interest expense60.7M86.3M144.4M108.0M89.5M37.2M40.3M45.0M50.6M44.5M
Income before tax1.05B796.2M702.8M680.3M366.8M517.5M498.8M369.0M355.0M184.6M
Income tax262.2M184.7M149.5M124.1M82.3M120.7M90.9M64.3M63.4M74.0M
Net income782.3M614.6M378.2M107.0M243.9M397.4M407.7M303.7M290.9M110.0M
Earnings per share, basic7.976.243.831.072.504.664.813.593.421.29
Earnings per share, diluted7.936.203.811.072.484.634.763.553.391.28

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents439.6M171.7M207.0M208.4M348.3M220.5M319.6M220.6M201.5M282.9M
Short-term investments00
Receivables1.09B1.04B1.01B865.0M799.0M609.4M586.5M564.8M528.1M483.5M
Inventory631.8M581.3M674.5M604.4M575.0M315.1M263.5M208.2M205.7M197.8M
Current assets2.39B2.00B2.87B2.01B1.88B1.21B1.22B1.05B989.7M1.02B
Property, plant and equipment2.16B1.96B1.77B1.63B1.55B1.24B1.11B1.03B1.01B915.9M
Goodwill4.19B4.10B4.07B3.88B3.94B3.03B2.36B2.32B2.43B2.23B
Total assets10.7B10.1B11.1B10.8B11.4B6.57B5.44B5.07B5.20B4.92B
Accounts payable338.8M280.8M251.7M264.2M225.7M156.9M149.3M152.9M135.9M133.5M
Current liabilities1.15B1.02B931.1M861.8M922.2M577.9M503.6M465.2M398.5M381.6M
Long-term debt1.81B1.92B3.12B3.02B2.95B1.65B1.15B1.18B1.32B1.48B
Total debt1.93B2.04B3.21B3.08B3.09B1.65B1.15B1.18B1.32B1.55B
Total liabilities3.54B3.53B4.75B4.73B4.88B2.68B2.02B1.89B1.98B2.11B
Shareholders' equity7.18B6.60B6.30B6.08B6.53B3.88B3.41B3.18B3.21B2.81B
Shares outstanding97.8M98.3M98.9M98.6M100.1M85.4M84.9M84.5M84.7M84.9M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations1.34B1.15B973.3M756.9M684.8M689.6M590.6M539.5M457.6M424.1M
Capital spending-369.0M-370.1M-360.3M-362.0M-287.6M-239.3M-214.5M-189.7M-165.5M-172.9M
Free cash flow972.4M778.0M613.0M395.0M397.2M450.4M376.0M349.8M292.2M251.2M
Cash from investing-512.5M388.8M-887.4M-383.3M-666.6M-1.15B-319.7M-213.2M-203.8M-104.3M
Cash from financing-568.2M-1.57B-85.2M-498.7M115.8M345.6M-163.1M-294.8M-356.2M-267.1M
Dividends paid-241.8M-219.9M-200.6M-183.5M-163.2M-133.8M-123.0M-112.5M-102.9M-93.2M
Share buybacks-235.5M-211.3M-11.8M-308.6M-55.8M-14.6M-51.2M-81.5M-65.5M-97.5M
Change in cash267.9M-35.3M-1.30M-140.0M127.8M-99.0M98.9M19.1M-81.4M34.1M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 17, 2026Insider tradeSEC
144 · Notice of proposed saleNov 13, 2026Other filingsSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
8-K · Current reportNov 12, 2026Current reportSEC
424B5 · ProspectusNov 12, 2026Offer documentSEC
144 · Notice of proposed saleNov 12, 2026Other filingsSEC
144 · Notice of proposed saleNov 10, 2026Other filingsSEC
FWP · Free writing prospectusNov 9, 2026Offer documentSEC
424B5 · ProspectusNov 6, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
S-3ASR · Registration statementNov 6, 2026Offer documentSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026Material contractSEC
8-K · Current reportNov 4, 2026ResultsSEC
8-K · Current reportOct 13, 2026Material contractSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
144 · Notice of proposed saleAug 18, 2026Other filingsSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
144 · Notice of proposed saleAug 12, 2026Other filingsSEC
10-Q · Quarterly reportAug 7, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026Meeting outcomeSEC
8-K/A · Current report, amendedAug 6, 2026Management or board changeSEC
8-K · Current reportAug 5, 2026ResultsSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
11-K · Annual report of an employee planJun 16, 2026Annual reportSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
ARS · Annual report to shareholdersJun 11, 2026Annual reportSEC
DEFA14A · Additional proxy materialJun 11, 2026Meeting noticeSEC
DEF 14A · Proxy statementJun 11, 2026Meeting noticeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
144 · Notice of proposed saleJun 5, 2026Other filingsSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
144 · Notice of proposed saleJun 4, 2026Other filingsSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
144 · Notice of proposed saleJun 2, 2026Other filingsSEC
SD · Specialized disclosureJun 1, 2026ESG reportSEC
10-K · Annual reportMay 29, 2026Annual reportSEC
3 · Initial statement of ownershipMay 14, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMay 12, 2026Big-stake noticeSEC
8-K · Current reportMay 11, 2026ResultsSEC
8-K · Current reportMay 7, 2026Management or board changeSEC
SCHEDULE 13G · Big-stake noticeApr 30, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2026Big-stake noticeSEC
8-K · Current reportApr 6, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
144 · Notice of proposed saleMar 5, 2026Other filingsSEC
10-Q · Quarterly reportFeb 6, 2026Quarterly reportSEC
8-K · Current reportFeb 4, 2026ResultsSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 21, 2025Other filingsSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
144 · Notice of proposed saleNov 18, 2025Other filingsSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 4, 2025Big-stake noticeSEC
4 · Change in ownershipOct 8, 2025Insider tradeSEC
144 · Notice of proposed saleOct 6, 2025Other filingsSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipAug 22, 2025Insider tradeSEC
144 · Notice of proposed saleAug 20, 2025Other filingsSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
144 · Notice of proposed saleAug 12, 2025Other filingsSEC
144 · Notice of proposed saleAug 11, 2025Other filingsSEC
144 · Notice of proposed saleAug 11, 2025Other filingsSEC
144 · Notice of proposed saleAug 11, 2025Other filingsSEC
144 · Notice of proposed saleAug 11, 2025Other filingsSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
3 · Initial statement of ownershipAug 6, 2025Insider tradeSEC
8-K · Current reportAug 6, 2025ResultsSEC
DEFA14A · Additional proxy materialJul 3, 2025Meeting noticeSEC
8-K · Current reportJul 3, 2025Management or board changeSEC
11-K · Annual report of an employee planJun 25, 2025Annual reportSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
144 · Notice of proposed saleJun 13, 2025Other filingsSEC
ARS · Annual report to shareholdersJun 12, 2025Annual reportSEC
DEFA14A · Additional proxy materialJun 12, 2025Meeting noticeSEC
DEF 14A · Proxy statementJun 12, 2025Meeting noticeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
144 · Notice of proposed saleJun 5, 2025Other filingsSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
10-K · Annual reportMay 29, 2025Annual reportSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
144 · Notice of proposed saleMay 20, 2025Other filingsSEC
8-K · Current reportMay 14, 2025ResultsSEC
8-K · Current reportMar 3, 2025Current reportSEC
10-Q · Quarterly reportFeb 7, 2025Quarterly reportSEC
8-K · Current reportFeb 5, 2025ResultsSEC
4 · Change in ownershipNov 27, 2024Insider tradeSEC
144 · Notice of proposed saleNov 25, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportNov 6, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedOct 21, 2024Big-stake noticeSEC
8-K · Current reportOct 7, 2024Material contractSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4/A · Change in ownership, amendedOct 2, 2024Insider tradeSEC
4 · Change in ownershipSep 17, 2024Insider tradeSEC
4 · Change in ownershipSep 12, 2024Insider tradeSEC
144 · Notice of proposed saleSep 10, 2024Other filingsSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
8-K · Current reportAug 6, 2024ResultsSEC
8-K · Current reportAug 1, 2024Meeting outcomeSEC
11-K · Annual report of an employee planJun 21, 2024Annual reportSEC

This page holds 200 of 694 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from STERIS plc (Ireland)’s releases

Common shares
97,500,110
Fully diluted
97,500,110

Fully diluted

LineShares
Common shares97,500,110

Share count over time

CountShares
Nov 22, 202697,500,110

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
Vanguard Total Stock Market Index Fund3.11MUS$656MJun 30, 2026
Vanguard 500 Index Fund2.54MUS$535MJun 30, 2026
Vanguard Mid-Cap Index Fund2.12MUS$447MJun 30, 2026
iShares Core S&P 500 ETF1.35MUS$284MJun 30, 2026
Fidelity 500 Index Fund1.26MUS$267MMay 31, 2026
Vanguard Health Care Fund1.1MUS$251MJul 31, 2026
Disciplined Value Mid Cap Fund1.03MUS$216MJun 30, 2026
Janus Henderson Enterprise Fund994KUS$209MJun 30, 2026
Vanguard Windsor Fund956KUS$218MJul 31, 2026
Vanguard Value Index Fund933KUS$196MJun 30, 2026
Show 50 holders
HolderSharesValueAs of
Invesco S&P 500 Equal Weight ETF896KUS$205MJul 31, 2026
MFS Massachusetts Investors Growth Stock Fund745KUS$158MMay 31, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF693KUS$146MJun 30, 2026
T. Rowe Price U.S. Large-Cap Core Fund, Inc.630KUS$133MJun 30, 2026
Touchstone Funds Group Trust-Touchstone Mid Cap Fund580KUS$122MJun 30, 2026
MFS Mid Cap Value Fund556KUS$117MJun 30, 2026
Vanguard Dividend Appreciation Index Fund555KUS$127MJul 31, 2026
Vanguard Institutional Index Fund533KUS$112MJun 30, 2026
State Street(R) SPDR(R) S&P(R) Dividend ETF462KUS$97.2MJun 30, 2026
iShares U.S. Medical Devices ETF459KUS$96.7MJun 30, 2026
MFS Mid Cap Growth Fund408KUS$86.8MMay 31, 2026
Equity Income Fund405KUS$92.4MJul 31, 2026
iShares Russell Mid-Cap ETF402KUS$84.7MJun 30, 2026
Vanguard Mid-Cap Growth Index Fund376KUS$79.1MJun 30, 2026
Fidelity Mid Cap Index Fund371KUS$84.7MJul 31, 2026
Massachusetts Investors Trust325KUS$68.4MJun 30, 2026
Vanguard Mid-Cap Value Index Fund315KUS$66.3MJun 30, 2026
Vanguard Health Care Index Fund295KUS$62.7MMay 31, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF234KUS$49.3MJun 30, 2026
Invesco Value Opportunities Fund228KUS$52MJul 31, 2026
Value Line Mid Cap Focused Fund, Inc.225KUS$47.4MJun 30, 2026
Schwab S&P 500 Index Fund220KUS$50.2MJul 31, 2026
iShares Russell 1000 Value ETF219KUS$46.1MJun 30, 2026
The U.S. Large Cap Value Series211KUS$48.3MJul 31, 2026
Old Westbury Small & Mid Cap Strategies Fund193KUS$44.1MJul 31, 2026
Fidelity Total Market Index Fund185KUS$39.4MMay 31, 2026
iShares ESG Aware MSCI USA ETF184KUS$39.2MMay 31, 2026
Invesco S&P 500 Quality ETF165KUS$37.6MJul 31, 2026
Nomura Mid Cap Growth Fund162KUS$34.2MJun 30, 2026
ClearBridge Mid Cap Fund157KUS$35.9MJul 31, 2026
First Trust Value Line Dividend Index Fund156KUS$32.9MJun 30, 2026
Dimensional U.S. Core Equity 2 ETF155KUS$35.3MJul 31, 2026
MFS Research Fund152KUS$32MJun 30, 2026
iShares Russell Mid-Cap Value ETF150KUS$31.6MJun 30, 2026
Fidelity Series Total Market Index Fund150KUS$31.8MMay 31, 2026
Eventide Dividend Opportunities Fund145KUS$30.5MJun 30, 2026
Small-MidCap Dividend Income Fund143KUS$30.4MMay 31, 2026
Janus Henderson Triton Fund131KUS$27.5MJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF127KUS$26.8MJun 30, 2026
Global Franchise Portfolio120KUS$25.4MJun 30, 2026

This page holds 50 of 712 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Madsen Julia
Officer: Sr. VP and GM, Life Sciences
Sale2,046USD 260.00US$532KNov 13, 2026
Burton Karen L
Officer: Sr. Vice Pres., CFO
Sale5,880USD 255.62US$1.5MNov 11, 2026
Sohi Mohsen
Director
Sale3,228USD 252.87US$816KNov 10, 2026
Sohi Mohsen
Director
Sale1,665USD 253.90US$423KNov 10, 2026
Sohi Mohsen
Director
Sale4,058USD 235.78US$957KAug 12, 2026
Zangerle John Adam
Officer: Sr. VP, Gen Counsel, and Sec.
Sale1,419USD 209.28US$297KJun 15, 2026
Carestio Daniel A
Director, Officer: President and CEO
Sale1,374USD 212.00US$291KJun 5, 2026
Carestio Daniel A
Director, Officer: President and CEO
Sale3,054USD 214.64US$656KJun 4, 2026
Breeden Richard C
Director
Sale1,481USD 209.51US$310KJun 2, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jacqueline B Kosecoff
Other companies: Alignment Healthcare, Inc. (Director · Since at least Mar 25, 2021); TriNet Group, Inc. (Director · Since at least Jan 15, 2020); GoodRx Holdings, Inc. (Director · Sep 23, 2020 – Dec 31, 2022 · Past); Houlihan Lokey, Inc. (Director · Jun 20, 2016 – May 22, 2025 · Past); Sealed Air Corporation (Director · May 19, 2016 – May 21, 2020 · Past); athenahealth Inc (Director · Mar 1, 2016 – Feb 11, 2019 · Past)
Director · Aug 31, 2015 – Aug 8, 2024 · Past
Paul E. Martin
Other companies: Owens Corning Inc (Board Member · Since at least Feb 3, 2021); Unisys Corporation New (Director · Since at least Feb 9, 2017); Ping Identity Holding Corp (Director · Jan 1, 2021 – Oct 18, 2022 · Past)
Director · Since at least May 5, 2021
David B Lewis
Other companies: H&R Block, Inc. (Director · Nov 1, 2010 – Sep 10, 2020 · Past); Kroger Company (the) (Director · Mar 1, 2010 – Jun 1, 2016 · Past)
Director · Jul 29, 2010 – Jul 21, 2021 · Past
Michael J. Tokich
Other companies: Teleflex Incorporated (Director · Since at least May 15, 2026); Mettler-Toledo International, Inc. (Director · Since at least Jan 20, 2026)
Sr. Vice Pres., CFO · Since at least Apr 7, 2022
Esther M Alegria
Other companies: Avid Bioservices Inc (Director · Dec 14, 2023 – Feb 5, 2025 · Past)
Director · Since at least Aug 8, 2024
John P Wareham
Other companies: ResMed Inc. (Director · Aug 8, 2016 – Nov 1, 2019 · Past)
Director · Aug 10, 2016 – Aug 9, 2017 · Past
Mohsen M. Sohi
Other companies: Baker Hughes Company (Director · Since at least Jan 25, 2023)
Director · Since at least Aug 3, 2022
Cary L MajorsSVP and President, Healthcare · Since at least May 7, 2019
Daniel A CarestioPresident and CEO, Director · Since at least Jun 2, 2025
David Allen JohnsonSr. VP. Surgical Solutions · Jul 26, 2012 – Aug 10, 2015 · Past
All 22 people
PersonSeat
John Adam ZangerleSr. VP, Gen Counsel, and Sec. · Since at least Aug 10, 2015
Julia MadsenSr. VP and GM, Life Sciences · Since at least May 31, 2022
Julie WinterVice President, Investor Relations and Corporate Communications · Since at least Oct 28, 2026
Kenneth E KohlerSVP & GM, AST · Since at least Jun 2, 2025
Kim DuncanVice President, Investor Relations and Risk Management · Dec 23, 2025 – Nov 5, 2026 · Past
Lindsey McGowanVP, Chf. Comp. & Quality Offc. · Since at least Jan 1, 2026
Loyal W WilsonDirector · Aug 8, 2013 – Jun 4, 2019 · Past
Mary Clare FraserSVP & Chief HRO · Since at least Jun 3, 2024
Nirav R ShahDirector · Since at least Aug 8, 2025
Pierre BouludDirector · Since at least May 7, 2026
Renato TamaroV.P. & Corporate Treasurer · Since at least Jun 1, 2026
Richard C BreedenDirector · Since at least May 21, 2024

Open People

Log in to ask 6ix AI your own questions about STERIS plc (Ireland).